BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 28696240)

  • 1. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.
    Sherry L; Kean R; McKloud E; O'Donnell LE; Metcalfe R; Jones BL; Ramage G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
    Tasneem U; Siddiqui MT; Faryal R; Shah AA
    J Pak Med Assoc; 2017 Jul; 67(7):986-991. PubMed ID: 28770873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
    J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
    Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
    Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    Boikov DA; Locke JB; James KD; Bartizal K; Sobel JD
    J Antimicrob Chemother; 2017 May; 72(5):1355-1358. PubMed ID: 28158577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
    Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
    J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
    Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
    Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
    Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis.
    Feng W; Yang J; Ji Y; Xi Z; Yang L; Zhu X; Ma Y
    Lett Appl Microbiol; 2020 Feb; 70(2):95-101. PubMed ID: 31705810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
    de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
    Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.
    Ghaddar N; Anastasiadis E; Halimeh R; Ghaddar A; Dhar R; AlFouzan W; Yusef H; El Chaar M
    BMC Infect Dis; 2020 Jan; 20(1):32. PubMed ID: 31931738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilms and vulvovaginal candidiasis.
    Rodríguez-Cerdeira C; Gregorio MC; Molares-Vila A; López-Barcenas A; Fabbrocini G; Bardhi B; Sinani A; Sánchez-Blanco E; Arenas-Guzmán R; Hernandez-Castro R
    Colloids Surf B Biointerfaces; 2019 Feb; 174():110-125. PubMed ID: 30447520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-biofilm activity of chlorhexidine digluconate against Candida albicans vaginal isolates.
    Alvendal C; Mohanty S; Bohm-Starke N; Brauner A
    PLoS One; 2020; 15(9):e0238428. PubMed ID: 32941438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.
    Danby CS; Boikov D; Rautemaa-Richardson R; Sobel JD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1403-6. PubMed ID: 22232293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.